Toshiba America Medical Systems is re-entering the U.S. molecular imaging market with a new PET/CT imaging system.
Called Celesteion, the new system sports wide gantry bores, measured at 90 cm for CT and 88 cm for PET. The scanner also has 450-picosecond time-of-flight resolution and 0.5-sec CT rotation with 0.5-mm 32-slice detectors. The system is pending 510(k) clearance from the U.S. Food and Drug Administration (FDA).
Celesteion also features 70-cm CT and PET field-of-views and 85-cm CT extended field-of-view, and it comes with Toshiba's adaptive iterative dose reduction (AIDR) 3D CT dose reduction technology; it also conforms to the Medical Imaging and Technology Alliance's (MITA) XR-29 Smart Dose Standard.
Toshiba unveiled Celesteion at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) meeting, taking place June 7-11 in St. Louis. The introduction marks a re-entry into nuclear medicine for Toshiba, which sold gamma cameras in the U.S. market in the 1990s but later pulled out as a wave of consolidation swept the segment.
